RxDoctor Payments Data

Dean Kane

Baltimore, MDNPI 1467429951

Payments from drug & device makers

What this record shows

21 manufacturers reported payments, led by AbbVie at 58.6% of the total. Reporting peaked in 2019 at $2,251 and has fallen 90.0% since, to $224 in 2025.

$3,663in general payments, 2019–2025

Across 70 payments — averaging $52.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Galderma Laboratories, L.p.$562
  • Sun Pharmaceutical Industries Inc.$177
  • LEO Pharma Inc.$121
  • Johnson & Johnson$114
  • Lilly USA, LLC$75
  • plus $467 from 15 others

What the payments were for

  • Food & beverage$1,60944%
  • Gifts$2,05456%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →